Osteogenesis Imperfecta (OI) is a hereditary disorder effecting approximately 1 in 20,000 births. Symptoms include; low bone mass, recurrent fractures, varying degrees of short stature and deformity. There is currently no disease specific quality of life (QoL) measure for children with OI. This study uses a mixed methods approach to develop a QoL measure for the paediatric OI population. Patient reported outcome measure development is an iterative process, moving back and forth between concept elicitation, questionnaire development, pre-testing and psychometric analysis. In order to encourage a balance between good content validity, alongside promoting a robust, reliable and responsive measure, the methods chosen involved several stage...
Osteogenesis imperfecta (OI) is a genetic disorder (prevalence: 1:10,000), leading to bone fragility...
OBJECTIVE: To explore the validity and reliability of the child perception questionnaire as an oral-...
Caroline Marr,1,* Alison Seasman,1,* Nick Bishop2 1Metabolic Bone Disease Team, 2Academic Unit of Ch...
Background: Osteogenesis imperfecta (OI) is a disorder of bone formation leading to low mineral dens...
Background Osteogenesis imperfecta (OI) is a group of rare inheritable disorders of connective tiss...
Background: Osteogenesis Imperfecta (OI) is a genetic condition resulting from a mutation in the gen...
BACKGROUND: Osteogenesis Imperfecta (OI) is a rare genetic condition characterised by increased bone...
Abstract Background Osteogenesis imperfecta (OI) is a disorder of bone formation leading to low mine...
Background: Osteogenesis imperfecta (OI) is a group of genetic disorders of collagen biosynthesis, c...
Despite the growing interest in understanding the psycho-social impact of rare genetic diseases, few...
Background: Osteogenesis Imperfecta (OI) is a genetic disorder also known as ‘brittle bone disease’....
Osteogenesis imperfecta (OI) is a heterogeneous heritable connective tissue disorder characterized b...
Osteogenesis imperfecta (OI) is a group of rare genetic disorders that affect bone formation. Patien...
OBJECTIVES: To study (1). changes in anthropometrics, joint range of motion (ROM), muscle strength, ...
Background Despite the growing interest in understanding the psycho-social impact of rare genetic di...
Osteogenesis imperfecta (OI) is a genetic disorder (prevalence: 1:10,000), leading to bone fragility...
OBJECTIVE: To explore the validity and reliability of the child perception questionnaire as an oral-...
Caroline Marr,1,* Alison Seasman,1,* Nick Bishop2 1Metabolic Bone Disease Team, 2Academic Unit of Ch...
Background: Osteogenesis imperfecta (OI) is a disorder of bone formation leading to low mineral dens...
Background Osteogenesis imperfecta (OI) is a group of rare inheritable disorders of connective tiss...
Background: Osteogenesis Imperfecta (OI) is a genetic condition resulting from a mutation in the gen...
BACKGROUND: Osteogenesis Imperfecta (OI) is a rare genetic condition characterised by increased bone...
Abstract Background Osteogenesis imperfecta (OI) is a disorder of bone formation leading to low mine...
Background: Osteogenesis imperfecta (OI) is a group of genetic disorders of collagen biosynthesis, c...
Despite the growing interest in understanding the psycho-social impact of rare genetic diseases, few...
Background: Osteogenesis Imperfecta (OI) is a genetic disorder also known as ‘brittle bone disease’....
Osteogenesis imperfecta (OI) is a heterogeneous heritable connective tissue disorder characterized b...
Osteogenesis imperfecta (OI) is a group of rare genetic disorders that affect bone formation. Patien...
OBJECTIVES: To study (1). changes in anthropometrics, joint range of motion (ROM), muscle strength, ...
Background Despite the growing interest in understanding the psycho-social impact of rare genetic di...
Osteogenesis imperfecta (OI) is a genetic disorder (prevalence: 1:10,000), leading to bone fragility...
OBJECTIVE: To explore the validity and reliability of the child perception questionnaire as an oral-...
Caroline Marr,1,* Alison Seasman,1,* Nick Bishop2 1Metabolic Bone Disease Team, 2Academic Unit of Ch...